As part of ICR, our clients span the Fortune 500, Nasdaq, FTSE 100, FTSEurofirst 300 and FTSE 250. ICR Consilium supports healthcare companies globally across all sub-sectors including life sciences, biopharma, medical technology, diagnostics, healthcare services and information technology, and through all stages of growth from early-stage development, to public offerings, to mature public companies. 

 

Latest news

overlay
19 Sep 2023

Introducing the next 10 years as ICR Consilium: staying true to our values

View news release Empty

Case studies

overlay
Horizon Discovery

Horizon Discovery is a world-leader in the application of gene editing and gene modulation technologies and is at the centre of innovation and drug discovery.

Horizon Discovery View all case studies

Our team

overlay

Our senior team has worked together for many years, delivering high-level strategic healthcare consultancy with seamless execution and unrivalled market intelligence.

View our team Empty